Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

The prognostic values of serum markers in hepatocellular carcinoma after invasive therapies based on real-world data.

  • Authors : Li B; Department of Clinical Laboratory, The Fifth Medical Center of Chinese PLA General Hospital, Beijing, China.; Liu A

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*pathology ; Liver Neoplasms/Liver Neoplasms/Liver Neoplasms/*pathology

  • Source: Journal of clinical laboratory analysis [J Clin Lab Anal] 2021 Sep; Vol. 35 (9), pp. e23932. Date of Electronic Publication: 2021 Aug 17.Publisher: Wiley Country of Publication: United States NLM ID: 8801384 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Report

Genomewide transcriptomic profiling identifies a gene signature for predicting recurrence in early-stage hepatocellular carcinoma.

  • Authors : Kakisaka T; Center for Gastrointestinal Research, Center from Translational Genomics and Oncology, Baylor Scott and White Research Institute and Charles A. Sammons Cancer Center, Baylor University Medical Center, Dallas, Texas, USA.; Department of Molecular Diagnostics and Experimental Therapeutics, Beckman Research Institute of City of Hope Comprehensive Cancer Center, Duarte, California, USA.

Subjects: Gene Expression Regulation, Neoplastic* ; Transcriptome*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*genetics

  • Source: Clinical and translational medicine [Clin Transl Med] 2021 Jun; Vol. 11 (6), pp. e405.Publisher: Wiley Country of Publication: United States NLM ID: 101597971 Publication Model: Print Cited Medium: Internet

تفاصيل العنوان

×
Academic Journal

Akt phosphorylation is a risk factor for early disease recurrence and poor prognosis in hepatocellular carcinoma.

  • Authors : Nakanishi K; Division of Pathology, National Cancer Center Research Institute, Tokyo, Japan.; Sakamoto M

Subjects: Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*metabolism ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*metabolism ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*mortality

  • Source: Cancer [Cancer] 2005 Jan 15; Vol. 103 (2), pp. 307-12.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

×
Academic Journal

Positive status of alpha-fetoprotein and des-gamma-carboxy prothrombin: important prognostic factor for recurrent hepatocellular carcinoma.

  • Authors : Kaibori M; First Department of Surgery, Kansai Medical University, 10-15 Fumizonocho, 570-8507 Moriguchi, Osaka, Japan. ; Matsui Y

Subjects: Biomarkers/Biomarkers/Biomarkers/*blood ; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*blood

  • Source: World journal of surgery [World J Surg] 2004 Jul; Vol. 28 (7), pp. 702-7. Date of Electronic Publication: 2004 Jun 08.Publisher: Wiley Country of Publication: United States NLM ID: 7704052 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
Academic Journal

Clinical significance of simultaneous determinations of alpha-fetoprotein and des-gamma-carboxy prothrombin in monitoring recurrence in patients with hepatocellular carcinoma.

  • Authors : Aoyagi Y; Department of Internal Medicine, Niigata University School of Medicine, Niigata, Japan.; Oguro M

Subjects: Biomarkers*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*blood ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*blood

  • Source: Cancer [Cancer] 1996 May 01; Vol. 77 (9), pp. 1781-6.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

×
Academic Journal

Protein induced by vitamin K absence or antagonist II as a prognostic marker in hepatocellular carcinoma. Comparison with alpha-fetoprotein.

  • Authors : Suehiro T; Department of Surgery II, Faculty of Medicine, Kyushu University, Fukuoka, Japan.; Sugimachi K

Subjects: Biomarkers*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*analysis ; Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/Carcinoma, Hepatocellular/*diagnosis

  • Source: Cancer [Cancer] 1994 May 15; Vol. 73 (10), pp. 2464-71.Publisher: Wiley Country of Publication: United States NLM ID: 0374236 Publication Model: Print Cited Medium: Print

تفاصيل العنوان

×
Editorial & Opinion

Development and validation of an artificial intelligence model for predicting post-transplant hepatocellular cancer recurrence.

Subjects: Liver Neoplasms*/Liver Neoplasms*/Liver Neoplasms*/surgery ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/diagnosis ; Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/Carcinoma, Hepatocellular*/surgery

  • Source: Cancer communications (London, England) [Cancer Commun (Lond)] 2023 Dec; Vol. 43 (12), pp. 1381-1385. Date of Electronic Publication: 2023 Oct 30.Publisher: Wiley Country of Publication: United States NLM ID: 101723675 Publication Model: Print-Electronic Cited Medium:

تفاصيل العنوان

×
  • 1-10 of  2,828 نتائج ل ""Local""